Nurtec is not a triptan. It belongs to a completely different drug class called gepants, which work through a distinct mechanism and lack several of the limitations that make triptans unsuitable for some migraine patients. The confusion is understandable because both drugs treat acute migraine attacks, but the similarities largely end there.
How Nurtec Works vs. Triptans
Nurtec (rimegepant) is a CGRP receptor antagonist. CGRP is a protein your body releases during a migraine that dilates blood vessels and drives the pain signaling cascade. Nurtec blocks the receptors for this protein, essentially stopping the chain reaction that produces migraine pain.
Triptans, like sumatriptan, work differently. They activate serotonin receptors (specifically 5-HT1B/1D receptors) located in the smooth muscle and lining of blood vessels in your head. When those receptors are activated, the vessels constrict, which reverses the dilation happening during a migraine and interrupts pain signals. This vasoconstriction is central to how triptans relieve migraines, but it’s also the source of their most significant drawback.
The Key Difference: Blood Vessel Constriction
Triptans physically narrow blood vessels. While they’re relatively selective for vessels in the head compared to the rest of the body, they can still constrict coronary arteries to some degree. That’s why triptans carry cardiovascular contraindications: people with a history of heart attack, stroke, uncontrolled high blood pressure, or certain types of heart disease are advised not to take them.
Nurtec does not constrict blood vessels. Lab studies using human coronary and cerebral arteries found that rimegepant, even at high concentrations, showed no active vasoconstrictive properties. Sumatriptan, tested under the same conditions, produced progressive, concentration-dependent constriction. This is a fundamental pharmacological difference, not just a minor detail. It means Nurtec doesn’t carry the same cardiovascular contraindications and precautions that triptans do, potentially filling a treatment gap for the substantial number of migraine patients who can’t safely use triptans.
What Nurtec Is Approved For
Nurtec has two FDA-approved uses, which is unusual for a migraine medication. It can treat an active migraine attack (acute treatment), and it can be taken regularly to reduce how often migraines occur (preventive treatment).
For acute treatment, the dose is 75 mg taken as needed when a migraine starts, with a maximum of one dose per 24 hours. For prevention of episodic migraine, the same 75 mg dose is taken every other day on a regular schedule. The tablet dissolves on your tongue without water, which is practical when nausea makes swallowing pills difficult during an attack. Triptans, by comparison, are only approved for acute treatment.
Side Effects
Nurtec’s side effect profile is mild compared to triptans. The most common adverse reaction in clinical trials was nausea, which occurred in about 2% to 2.7% of patients taking Nurtec versus less than 1% on placebo. Abdominal pain or indigestion affected roughly 2.4% of patients using it for prevention. Triptans, on the other hand, are known for causing chest tightness, tingling, drowsiness, and a heavy or warm sensation that some patients find intolerable.
Drug Interactions to Know About
Nurtec is broken down in the body primarily by a liver enzyme called CYP3A4. Medications that strongly inhibit this enzyme can increase Nurtec’s concentration in your blood by roughly fourfold, so combining them should be avoided. Common strong CYP3A4 inhibitors include certain antifungal medications and some antibiotics. With moderate inhibitors of this enzyme, a 48-hour gap between Nurtec doses is recommended instead of the usual 24 hours.
On the flip side, drugs that rev up CYP3A4 activity (called inducers) can reduce Nurtec’s effectiveness dramatically. One study found that the strong inducer rifampin cut Nurtec’s blood levels by 80%, enough to potentially make it ineffective. Weak inhibitors and inducers are generally not a concern.
Can You Take Nurtec if Triptans Don’t Work?
Because Nurtec and triptans target entirely different pathways, a poor response to triptans doesn’t predict how you’ll respond to Nurtec. Some people who found triptans ineffective respond well to gepants, and vice versa. The two classes are also sometimes used by the same patient for different situations: a triptan for severe, fast-onset attacks and Nurtec for milder episodes or as a preventive, for example. Since Nurtec doesn’t constrict blood vessels, it offers an option for people whose cardiovascular health rules out triptans entirely.